Cite

HARVARD Citation

    Kwakman, R. et al. (n.d.). Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in Western cancer patients. European journal of cancer. pp. S69-. [Online]. 
  
Back to record